Jossie Rotman

PD-L1 and PD-L2 Expression in Cervical Cancer: Regulation and Biomarker Potential

Jossie Rotman, Leontine A. S. den Otter, Maaike C.G. Bleeker et al. · Frontiers in Immunology · 2020 · 107 citations · Full text

Medicine, Cancer Biology, Oncology +14

Efficacy of PD-1 blockade in cervical cancer is related to a CD8+FoxP3+CD25+ T-cell subset with operational effector functions despite high immune checkpoint levels

A. Marijne Heeren, Jossie Rotman, Anita G.M. Stam et al. · Journal for ImmunoTherapy of Cancer · 2019 · 58 citations · Full text

Life Sciences, Immunology, Oncology +17

THE SIGNIFICANCE OF MUCOPOLYSACCHARIDES IN AMYLOID

Mordechai Pras, Zvi Nevo, Jossie Rotman et al. · Journal of Histochemistry & Cytochemistry · 1971 · 41 citations

Life Sciences, Biochemistry, Pathology +10

Adenocarcinoma of the Uterine Cervix Shows Impaired Recruitment of cDC1 and CD8+ T Cells and Elevated β-Catenin Activation Compared with Squamous Cell Carcinoma

Jossie Rotman, A. Marijne Heeren, Awa A. Gassama et al. · Clinical Cancer Research · 2020 · 39 citations · Full text

Medicine, Immunology, Oncology +17

‘DURVIT’: a phase-I trial of single low-dose durvalumab (Medi4736) IntraTumourally injected in cervical cancer: safety, toxicity and effect on the primary tumour- and lymph node microenvironment

Jossie Rotman, Constantijne H. Mom, Ekaterina S. Jordanova et al. · BMC Cancer · 2018 · 32 citations · Full text

Medicine, Oncology, Pharmacology +17